ReachMD

Be part of the knowledge.™

Nephrology

236

LikeLikedUnlike

Episodes 16-30 of 31

- Gerasimos S. Filippatos, MD, FESC, FHFA, FHFSA(h)
  Peer
- Javier Morales, MD, FACP, FACE
  Peer
- Angela Yee-Moon Wang, MD, FACP, FACE
  Peer
12
CME/CE
A New Option for Cardiorenal Protection for Patients with CKD in T2D
A New Option for Cardiorenal Protection for Patients with CKD in T2D
0.25 credits
- Mikhail Kosiborod, MD
  Peer
- Austin G. Stack, MBBCh, MD, MSc, FASN, FRCPI
  Peer
22
CME/CE
New Perspectives in Managing HF and HK – The Cardiorenal Angle
New Perspectives in Managing HF and HK – The Cardiorenal Angle
0.25 credits
- Eugene E. Wright, Jr., MD
  Peer
- Jolanta Małyszko, MD, PhD
  Peer
- María José Soler, MD, PhD
  Peer
15
CME/CE
Nonsteroidal MRAs: Latest Evidence of Cardiorenal Protection in CKD and T2D
Nonsteroidal MRAs: Latest Evidence of Cardiorenal Protection in CKD and T2D
0.25 credits
- Josep Comin-Colet, MD, PhD
  Peer
12
CME/CE
Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure
Beyond Anemia: Addressing Iron Deficiency in Patients with Heart Failure
0.25 credits
- Javed Butler, MD, MBA, MPH
  Peer
- Stefan D. Anker, MD, PhD
  Peer
19
CME/CE
Approaching Optimal RAASi Therapy with Use of Potassium Binders: DIAMOND Topline Results
Approaching Optimal RAASi Therapy with Use of Potassium Binders: DIAMOND Topline Results
0.25 credits
- George L. Bakris, MD, FAHA, FASN
  Peer
- Giuseppe M.C. Rosano, MD, PhD, FESC, FHFA
  Peer
10
CME/CE
Optimizing RAASi Therapy: The Role of Personalized Medicine
Optimizing RAASi Therapy: The Role of Personalized Medicine
0.25 credits
- Frederic Rahbari-Oskoui, MD, MSc
  Peer
- Melanie Betz, MS, RD, CSR, CSG
  Peer
2
Nephrology
Expert Interview: Nutrition in ADPKD
Expert Interview: Nutrition in ADPKD
- Arlene B. Chapman, MD
  Peer
2
Nephrology
Investigator Interview: Volume Progression in ADPKD
Investigator Interview: Volume Progression in ADPKD
4
Nephrology
Investigator Interview: Treating Rapidly Progressing Patients with ADPKD
Investigator Interview: Treating Rapidly Progressing Patients with ADPKD
- Arlene B. Chapman, MD
  Peer
- Michel Chonchol, MD
  Peer
4
CME/CE
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 4: Emerging Therapies
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 4: Emerging Therapies
0.50 credits
- George L. Bakris, MD, FAHA, FASN
  Peer
- Rajiv Agarwal, MBBS, MD, FASN, BRCU
  Peer
- Bertram Pitt, MD
  Peer
12
CME/CE
FIGARO-DKD and FIDELITY Analysis: Key Takeaways
FIGARO-DKD and FIDELITY Analysis: Key Takeaways
0.25 credits
2
Nephrology
A Patient's Journey with ADPKD
A Patient's Journey with ADPKD
- Michel Chonchol, MD
  Peer
- Frederic Rahbari-Oskoui, MD, MSc
  Peer
4
CME/CE
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 3: Management
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 3: Management
0.50 credits
- Matthew B. Lanktree, MD, PhD
  Peer
- Neera Dahl, MD, PhD
  Peer
2
CME/CE
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 2: Progression and Prognostication
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 2: Progression and Prognostication
0.50 credits
- Arlene B. Chapman, MD
  Peer
- Matthew B. Lanktree, MD, PhD
  Peer
1
CME/CE
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 1: Detection and Diagnosis
Optimizing the Care and Quality of Life for Patients with ADPKD – Part 1: Detection and Diagnosis
0.50 credits

Program Chapters

Segment Chapters

Playlist:

Recommended